Logo

American Heart Association

  1
  0


Final ID: 33

A Novel Imaging Biomarker to Make Precise Outcome Predictions for Patients with Acute Ischemic Stroke

Abstract Body: Introduction: Net water uptake (NWU) is a novel biomarker which measures edema and tissue injury from the degree of hypoattenuation on non-contrast CT and may serve as a precision tool for predicting outcomes after acute ischemic stroke (AIS). Using our recently developed algorithm, this study aimed to evaluate the relationship between NWU and post-stroke neurologic outcomes, including language impairment and motor weakness.

Methods: Consecutive patients treated for AIS at certified stroke centers in Houston, TX were included. Patients’ precise functional outcomes at hospital discharge were recorded including decreased level of consciousness, presence of language impairment, visual deficit, arm and leg weakness, need for walking assistance, and gastrostomy placement. The primary outcome for this study was the performance of calculated NWU and clinical variables to predict language impairment at discharge. Baseline characteristics were compared, and then univariate and multivariate logistic regression were used to evaluate the association between clinical variables, imaging data, and the precise neurological outcomes.

Results: Among 776 patients with AIS, average age was 67.0 +/- 14.8, 47.8% were female, median NIHSS was 10 [5,18], median ASPECTS was 9 [7,10], 42.6% received tPA, and 67.1% had a large vessel occlusion (see Table 1). In univariate logistic regression, higher NWU (OR 1.45, CI 1.30-1.63) and lower ASPECTS (OR 0.68, CI 0.63-0.74) were both significantly associated with higher likelihood of language impairment and other deficits at discharge (see Table 2). Additionally, higher NWU in all ten regions was significantly associated with deficit at discharge. In multivariate logistic regression, certain clinical and imaging variables remained significantly associated as described in Table 3. The ASPECTS and NWU-based regression models were directly compared when predicting language impairment using ROC curve analysis, and areas under the curve were 0.838 vs. 0.851 respectively (p = 0.152 with Delong test, see Figure 1).

Conclusion: The novel NWU biomarker was significantly associated with precise post-AIS outcomes at discharge. When controlling for confounders, NWU was non-inferior to ASPECTS. Moving forward, region-based and overall NWU will need to be studied with long-term patient outcomes. Ultimately, this novel and open-access imaging biomarker could be used in the emergency setting to guide treatment decision-making and patient counseling.
  • Mallavarapu, Monica  ( UT Health Houston , Houston , Texas , United States )
  • Kim, Hyun Woo  ( TEXAS STROKE INSTITUTE , Plano , Texas , United States )
  • Iyyangar, Ananya  ( UT Health Houston , Houston , Texas , United States )
  • Salazar-marioni, Sergio  ( UT Health Houston , Houston , Texas , United States )
  • Yoo, Albert  ( TEXAS STROKE INSTITUTE , Plano , Texas , United States )
  • Giancardo, Luca  ( UT Health Houston , Houston , Texas , United States )
  • Sheth, Sunil  ( UT Health Houston , Houston , Texas , United States )
  • Jeevarajan, Jerome  ( UT Health Houston , Houston , Texas , United States )
  • Author Disclosures:
    Monica Mallavarapu: DO NOT have relevant financial relationships | Hyun Woo Kim: DO NOT have relevant financial relationships | Ananya Iyyangar: DO NOT have relevant financial relationships | Sergio Salazar-Marioni: DO NOT have relevant financial relationships | Albert Yoo: DO have relevant financial relationships ; Research Funding (PI or named investigator):Medtronic:Past (completed) ; Ownership Interest:Nicolab:Active (exists now) ; Ownership Interest:Galaxy Medical:Active (exists now) ; Ownership Interest:Gravity Medical:Active (exists now) ; Ownership Interest:Insera Therapeutics:Active (exists now) ; Consultant:Zoll Circulation:Active (exists now) ; Consultant:Nicolab:Active (exists now) ; Consultant:Rapid Medical:Active (exists now) ; Consultant:Cerenovus:Active (exists now) ; Consultant:Penumbra:Active (exists now) ; Research Funding (PI or named investigator):Genentech:Past (completed) ; Research Funding (PI or named investigator):Stryker:Past (completed) ; Research Funding (PI or named investigator):Penumbra:Past (completed) ; Research Funding (PI or named investigator):Cerenovus:Past (completed) | Luca Giancardo: DO have relevant financial relationships ; Consultant:Panda Health:Past (completed) | Sunil Sheth: DO have relevant financial relationships ; Consultant:Medtronic:Active (exists now) ; Research Funding (PI or named investigator):NIH:Active (exists now) ; Ownership Interest:Motif:Active (exists now) ; Consultant:Imperative Care:Past (completed) ; Consultant:Balt:Active (exists now) ; Researcher:Viz.AI:Past (completed) ; Consultant:Penumbra:Past (completed) | Jerome Jeevarajan: DO NOT have relevant financial relationships
Meeting Info:
Session Info:

Imaging Oral Abstracts I

Wednesday, 02/05/2025 , 09:15AM - 10:45AM

Oral Abstract Session

More abstracts on this topic:
More abstracts from these authors:
Final infarct volume reduction may mediate EVT effects on mortality

Ballekere Anjan Nagesh, Iyyangar Ananya, Azeem Hussain, Sheth Sunil, Ebirim Emmanuel, Lee Eunyoung, Le Ngoc Mai

Evaluating Accuracy in Defining Large Core Infarction: A Comparison of Non-Contrast Head CT ASPECTS and CT Perfusion Core Infarct Volume

Le Ngoc Mai, Ballekere Anjan Nagesh, Azeem Hussain, Iyyangar Ananya, Bajaj Ritesh, Lee Eunyoung, Ebirim Emmanuel, Sheth Sunil

You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.


   Rate this abstract  (Maximum characters: 500)